The Innovator Brand of Rabeprazole IV1
5 P’s Action Advantage2
Pace – Highest pKa: faster activation rate
Power – More effective: 24 hours acid suppression
Precision – Non Enzymatic metabolism: Least drug-drug interaction
Protection – Mucus defense: Mucus secretion & mucin syntheses
Predictability – Uniform action: Least inter-individual action
References:
1. IV Rabeprazole in acute erosive GERD & acute bleeding peptic ulcer Cadila Pharmaceuticals Ltd, Dholka, India. Study Code: CPLG1AM1203REG02.
2. Clinical Study Report IV Rabeprazole in Prevention of Pulmonary Acid Aspiration During Surgery Study Code: IV Rabeprazole by Dr. Amol Wagh, Dr. Sandesh Deolekar; Study Center: Grant Government Medical College and Sir J.J. Group of hospitals, Byculla, Mumbai-400008.
Maharashtra and Dr. D. Y. Patil Hospital and Research Centre, Navi Mumbai-400706. Maharashtra
4th Floor, 393 Goodwill Bldg.,
Senator Gil Puyat Avenue,
Brgy. Bel-Air, Makati City